Cargando…
SSRI use and clinical outcomes in epithelial ovarian cancer
Selective serotonin reuptake inhibitor (SSRI) use is common among ovarian cancer patients. We examined the effect of SSRIs on survival and progression in ovarian cancer patients and effects of 5-HT on ovarian cancer cell (OCC) proliferation. Ovarian cancer patients from a 6-site study between 1994 a...
Autores principales: | Christensen, Desiré K., Armaiz-Pena, Guillermo N., Ramirez, Edgardo, Matsuo, Koji, Zimmerman, Bridget, Zand, Behrouz, Shinn, Eileen, Goodheart, Michael J., Bender, David, Thaker, Premal H., Ahmed, Amina, Penedo, Frank J., DeGeest, Koen, Mendez, Luis, Domann, Frederick, Sood, Anil K., Lutgendorf, Susan K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5078084/ https://www.ncbi.nlm.nih.gov/pubmed/27121207 http://dx.doi.org/10.18632/oncotarget.8891 |
Ejemplares similares
-
Diurnal Cortisol and Survival in Epithelial Ovarian Cancer
por: Schrepf, Andrew, et al.
Publicado: (2015) -
DNA methylation changes in ovarian cancer are cumulative with disease progression and identify tumor stage
por: Watts, George S, et al.
Publicado: (2008) -
The Role of LEF1 in Endometrial Gland Formation and Carcinogenesis
por: Shelton, Dawne N., et al.
Publicado: (2012) -
Mitochondria in epithelial ovarian carcinoma exhibit abnormal phenotypes and blunted associations with biobehavioral factors
por: Bindra, Snehal, et al.
Publicado: (2021) -
The SSRI Clinic: Improving SSRI Prescribing Safety in Outpatient CAMHS Clinic
por: Morgan, Tammy, et al.
Publicado: (2022)